Poland· PL-100391813
Axumin
A fluciclovine (18f) product containing flucuclovinum [18f], registered in Poland by Blue Earth Diagnostics Ireland Ltd. The same ATC class is registered in 10 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Fluciclovine (18f) is registered in 10 of 19 countries.
Countries holding a registration under ATC V09IX12 (fluciclovine (18f)), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Fluciclovine (18f) · ATC V09IX12
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Flucuclovinum [18F]
- Manufacturer
- Blue Earth Diagnostics Ireland Ltd
- Country
- Poland (PL)
- ATC code
- V09IX12
- ATC class
- Fluciclovine (18F)
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under V09IX12
Fluciclovine (18f), as other registers publish it.
- DenmarkAxuminBlue Earth Diagnostics Ireland Ltd
- DenmarkAxuminBlue Earth Diagnostics Ireland Ltd
- NorwayAxuminBlue Earth Diagnostics Ireland Ltd
- FinlandAxuminBlue Earth Diagnostics Ireland Ltd
- FinlandAxuminBlue Earth Diagnostics Ireland Ltd
- IcelandAxuminBlue Earth Diagnostics Ireland Ltd
- IcelandAxuminBlue Earth Diagnostics Ireland Ltd
- NorwayAxuminBlue Earth Diagnostics Ireland Ltd
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b04b7f61-71ba-4559-a1a5-f278a82e9bf4 GET /v1/drugs/b04b7f61-71ba-4559-a1a5-f278a82e9bf4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań",
"source": "urpl",
"strength": "1600 MBq/ml",
"packaging": "Rpz ¦ EU/1/17/1186/001 ¦ 123744\n1 fiol. \nRpz ¦ EU/1/17/1186/003 ¦ 131380\n1 fiol.",
"substance": "Flucuclovinum [18F] 1600 MBq/ml",
"common_name": "Flucuclovinum [18F]",
"pl_product_id": "100391813",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about fluciclovine (18f).
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.